In NSCLC, the immunotherapy responders (high-PD-L1 group) had increased Veillonella dispar compared to the low-PD-L1 group, which was enriched in Haemophilus influenzae and Neisseria perflava [112]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.